000 | 01459 a2200385 4500 | ||
---|---|---|---|
005 | 20250513030606.0 | ||
264 | 0 | _c19940125 | |
008 | 199401s 0 0 eng d | ||
022 | _a0001-6772 | ||
024 | 7 |
_a10.1111/j.1748-1716.1993.tb09614.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDunning, B E | |
245 | 0 | 0 |
_aTissue-specific reduction of galanin content in the pancreas in alloxan diabetes in the mouse. _h[electronic resource] |
260 |
_bActa physiologica Scandinavica _cOct 1993 |
||
300 |
_a215-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdrenal Glands _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xblood |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGalanin |
650 | 0 | 4 |
_aInsulin _xpharmacology |
650 | 0 | 4 |
_aIslets of Langerhans _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred Strains |
650 | 0 | 4 |
_aNeuropeptides _xmetabolism |
650 | 0 | 4 | _aOrgan Specificity |
650 | 0 | 4 |
_aPancreas _xdrug effects |
650 | 0 | 4 |
_aPeptides _xanalysis |
650 | 0 | 4 | _aReference Values |
700 | 1 | _aAhrén, B | |
773 | 0 |
_tActa physiologica Scandinavica _gvol. 149 _gno. 2 _gp. 215-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1748-1716.1993.tb09614.x _zAvailable from publisher's website |
999 |
_c7504983 _d7504983 |